Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

2021 ◽  
Author(s):  
Maria Fleseriu ◽  
Alexander Dreval ◽  
Irina Bondar ◽  
Gulnar Vagapova ◽  
Djuro Macut ◽  
...  
Keyword(s):  
Randomised Controlled Trial ◽  
Controlled Trial ◽  
Somatostatin Receptor ◽  
Receptor Ligands ◽  
Phase 3 ◽  
Somatostatin Receptor Ligands ◽  
Randomised Controlled

Axilladissektion beim frühen Mammakarzinom mit nodalen Mikrometastasen fraglich

2020 ◽  
Vol 52 (02) ◽  
pp. 73-76
Keyword(s):  
Randomised Controlled Trial ◽  
Sentinel Node ◽  
Axillary Dissection ◽  
Controlled Trial ◽  
Phase 3 ◽  
Randomised Controlled

Galimberti V et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 2013; 14: 297–305. doi: 10.1016/S1470- 2045(13)70035-4

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

The Lancet ◽  
2009 ◽  
Vol 374 (9698) ◽  
pp. 1331-1338 ◽  
Author(s):  
Noriyuki Katsumata ◽  
Makoto Yasuda ◽  
Fumiaki Takahashi ◽  
Seiji Isonishi ◽  
Toshiko Jobo ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Randomised Controlled Trial ◽  
Controlled Trial ◽  
Advanced Ovarian Cancer ◽  
Open Label ◽  
Phase 3 ◽  
Dose Dense ◽  
Randomised Controlled
Sign in / Sign up

Export Citation Format

Share Document